Dr. Gertsik advises employers on emerging and chronic health risks, providing actionable guidance to optimize cancer care at both the individual and organizational level. This includes improving cancer outcomes and reducing wasteful medical spend, benefits and formulary design, precision medicine adoption, case management approaches, and the use of the latest early detection technologies. Prior to joining PHM, Natalya was a consultant at McKinsey & Company where she worked across industries including biopharmaceuticals, health insurance and the social sector. Natalya received her PhD in Biochemistry from the Weill Cornell Graduate School of Medical Sciences.